Nonetheless, we observed significant protection of pancreatic cancer cells from gemcitabine toxicity on co-treatment with exogenous CXCL12, indicating a role for CXCL12–CXCR4 signalling axis in pancreatic cancer chemoresistance. Here, CXCR4 is linked to pancreatic neoplasm.